• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form EFFECT filed by Cerevel Therapeutics Holdings Inc.

    8/6/24 12:15:10 AM ET
    $CERE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $CERE alert in real time by email
    Notice of Effectiveness
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    Notice of Effectiveness
    Effectiveness Date: August 5, 2024
    Accession Number: 0001193125-24-190812
    Submission Type: POS AM
    CIK: 0001805387
    Company Name: Cerevel Therapeutics Holdings, Inc.
    File Number: 333-264812
    Get the next $CERE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CERE

    DatePrice TargetRatingAnalyst
    12/8/2023$45.00Outperform → Market Perform
    TD Cowen
    11/20/2023$25.00Neutral
    JP Morgan
    9/28/2023$33.00Overweight
    Piper Sandler
    8/3/2023$36.00 → $31.00Buy → Neutral
    BofA Securities
    5/4/2023$30.00Equal Weight → Overweight
    Wells Fargo
    4/10/2023Outperform
    TD Cowen
    3/17/2023$40.00 → $29.00Overweight → Neutral
    JP Morgan
    3/16/2023$22.00Hold
    Berenberg
    More analyst ratings